SCHEMBL4267754

SCHEMBL4267754

O=C(O)c1noc2c1CN(C(=O)c1ccc3ncccc3c1)CC2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.45
DPP8 Q6V1X1 1/20 0.45
HPGD P15428 1/20 0.43
CXCR3 P49682 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
HSP90AA1 P07900 2/20 0.40
LMNA P02545 2/20 0.40
CAPN1 P07384 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
ALOX15 P16050 1/20 0.40
HTT P42858 1/20 0.40
PLK1 P53350 1/20 0.40
ALDH1A1 P00352 4/20 0.40
CCR3 P51677 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2590848 0.82 ALDH1A1 (0.52) HPGDNPC1RAB9AHSP90AA1LMNA
SCHEMBL2588858 0.79 DPP4 (0.50) DPP4DPP8HPGDCXCR3LMNA
SCHEMBL4267349 0.77 HSP90AA1 (0.47) NPC1RAB9AHSP90AA1ALDH1A1MAPT
SCHEMBL4270537 0.76 HSP90AA1 (0.46) HPGDNPC1RAB9AHSP90AA1LMNA
SCHEMBL4267339 0.76 HSP90AA1 (0.46) HPGDNPC1RAB9AHSP90AA1ALDH1A1
SCHEMBL4267221 0.76 HPGD (0.55) HPGDNPC1RAB9AHSP90AA1LMNA
SCHEMBL5532207 0.75 GRM5 (0.39) DPP4DPP8CXCR3LMNACAPN1
SCHEMBL4259746 0.75 LMNA (0.50) HPGDNPC1RAB9AHSP90AA1LMNA
SCHEMBL3296940 0.74 HPGD (0.56) DPP4DPP8HPGDLMNACAPN1
SCHEMBL4267314 0.73 NPC1 (0.40) HPGDNPC1RAB9AHSP90AA1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments GRUENENTHAL GMBH (DE) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments P2RX5, P2RX4, P2RX7 DPP4 249/4885DPP8 1283/4885HPGD 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.